Filing search / VBI Vaccines Inc / "Nature"

8-K

EX-99.1

VBIVQ VBI Vaccines Inc

2 Aug 24

VBI Vaccines Provides an Update on its Restructuring Proceedings

4:05pm

parties; changes in the size and nature of competitors; the ability to retain key executives and scientists; and the ability to secure and enforce legal

8-K

EX-99.1

VBIVQ VBI Vaccines Inc

30 Jul 24

VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives

10:28am

to manufacture product candidates on a commercial scale or in collaborations with third parties; changes in the size and nature of competitors; the ability

8-K

EX-99.1

VBIVQ VBI Vaccines Inc

29 May 24

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

8:00am

ability to manufacture product candidates on a commercial scale or in collaborations with third parties; changes in the size and nature of competitors

8-K

EX-1.1

VBIVQ VBI Vaccines Inc

15 May 24

VBI Vaccines Reports First Quarter 2024 Financial Results

4:18pm

is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature … that the Manager has rendered advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Company, in connection

8-K

EX-99.1

VBIVQ VBI Vaccines Inc

15 May 24

VBI Vaccines Reports First Quarter 2024 Financial Results

4:18pm

in the size and nature of competitors; the ability to retain key executives and scientists; and the ability to secure and enforce legal rights related

424B5

j0w3da6 e6vth

15 May 24

Prospectus supplement for primary offering

4:16pm

8-K

EX-99.1

h2spsb7w27eu7l0e

16 Apr 24

VBI Vaccines Reports Full Year 2023 Financial Results

8:00am

8-K

EX-99.2

ma8wid

11 Apr 24

VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

4:07pm

8-K

EX-10.1

2jw69lr

11 Apr 24

VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

4:07pm

8-K

EX-99.1

303rqz6bvkajtn

11 Apr 24

VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

4:07pm